This inventor holds 4 USPTO granted patents. Top assignees: Med USA, Materials Evolution and Development USA, Inc.. Active years: 1999-2006.
Location History:
- San Antonio, TX (US) (1999 - 2006)
- Tega Cay, SC (US) (2002 - 2006)
Company Filing History:
Years Active: 1999-2006
Title: Innovations by Charles A McLaughlin
Introduction
Charles A McLaughlin is a notable inventor based in Tega Cay, South Carolina. He holds a total of four patents, showcasing his contributions to the field of biomedical engineering. His work primarily focuses on implantable systems that enhance cell growth control and drug delivery in vascular tissues.
Latest Patents
One of his latest patents is an "Implantable system for cell growth control." This innovative system includes a relatively non-biodegradable porous linked fibrous biomaterial that effectively controls and directs cell growth and angiogenesis from adjacent vascular tissue into the implant. The infection shield embodiments stimulate cell growth and angiogenesis, blocking the passage of pathogenic microorganisms along percutaneously implanted objects. In drug delivery embodiments, a reservoir of the same biomaterial may contain either a cell culture system enclosed within a porous sealable interior chamber or a biodegradable matrix with dispersed drugs. After implantation, cultured cells obtain nutrients and oxygen through diffusion, while metabolic products, including drugs, diffuse away. The second embodiment allows for the progressive dissolution of the biodegradable matrix, releasing drugs into surrounding tissue fluid. Both embodiments are designed to stimulate angiogenesis from surrounding vascular tissue into the reservoir.
Another significant patent is the "Porous drug delivery system," which shares similar features with the previous invention. This system also utilizes a non-biodegradable porous linked fibrous biomaterial to control cell growth and angiogenesis. The infection shield and drug delivery functionalities are designed to enhance the effectiveness of implanted devices in the body.
Career Highlights
Throughout his career, Charles has worked with several companies, including Med USA and Materials Evolution and Development USA, Inc. His experience in these organizations has contributed to his expertise in developing innovative biomedical solutions.
Collaborations
Charles has collaborated with notable individuals in his field, including Mark B Lyles and Glenn A Halff. These partnerships have likely enriched his work and led to further advancements in his inventions.
Conclusion
Charles A McLaughlin's contributions to the field of biomedical engineering through his innovative patents demonstrate his commitment to improving medical technology. His work continues to influence the development of effective solutions for drug delivery and cell growth control.